Abstract: The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of .beta.-agonists. The invention also provides kits useful for this purpose.
Type:
Grant
Filed:
March 3, 1997
Date of Patent:
December 5, 2000
Assignees:
The Regents of the University of California, The Trustees of Columbia University in the City of New York, The Penn State Research Foundation, National Jewish Medical and Research Center, Wisconsin Alumni Research Center, Thomas Jefferson University, Brigham and Women's Hospital
Inventors:
Jeffrey M. Drazen, Vern Chinchilli, Richard Martin, Robert Lemanske, Jean G. Ford, James E. Fish, Homer Boushey